MCRB
Price
$0.81
Change
+$0.04 (+5.19%)
Updated
Oct 11 closing price
25 days until earnings call
ORMP
Price
$2.38
Change
-$0.00 (-0.00%)
Updated
Oct 11 closing price
27 days until earnings call
Ad is loading...

MCRB vs ORMP

Header iconMCRB vs ORMP Comparison
Open Charts MCRB vs ORMPBanner chart's image
Seres Therapeutics
Price$0.81
Change+$0.04 (+5.19%)
Volume$3.87M
CapitalizationN/A
Oramed Pharmaceuticals
Price$2.38
Change-$0.00 (-0.00%)
Volume$81.26K
CapitalizationN/A
View a ticker or compare two or three
MCRB vs ORMP Comparison Chart
Loading...
MCRB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
MCRB vs. ORMP commentary
Oct 12, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCRB is a Hold and ORMP is a Sell.

COMPARISON
Comparison
Oct 12, 2024
Stock price -- (MCRB: $0.77 vs. ORMP: $2.38)
Brand notoriety: MCRB and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MCRB: 217% vs. ORMP: 35%
Market capitalization -- MCRB: $144.17M vs. ORMP: $99.48M
MCRB [@Biotechnology] is valued at $144.17M. ORMP’s [@Biotechnology] market capitalization is $99.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MCRB’s FA Score shows that 0 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • MCRB’s FA Score: 0 green, 5 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, ORMP is a better buy in the long-term than MCRB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MCRB’s TA Score shows that 3 TA indicator(s) are bullish while ORMP’s TA Score has 4 bullish TA indicator(s).

  • MCRB’s TA Score: 3 bullish, 7 bearish.
  • ORMP’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ORMP is a better buy in the short-term than MCRB.

Price Growth

MCRB (@Biotechnology) experienced а -8.03% price change this week, while ORMP (@Biotechnology) price change was -1.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

MCRB is expected to report earnings on Mar 11, 2025.

ORMP is expected to report earnings on Nov 08, 2024.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MCRB($144M) has a higher market cap than ORMP($99.5M). ORMP YTD gains are higher at: 2.814 vs. MCRB (-45.000). ORMP has higher annual earnings (EBITDA): 25.5M vs. MCRB (-139.66M). ORMP has more cash in the bank: 153M vs. MCRB (71.2M). ORMP has less debt than MCRB: ORMP (486K) vs MCRB (213M). MCRB has higher revenues than ORMP: MCRB (374K) vs ORMP (0).
MCRBORMPMCRB / ORMP
Capitalization144M99.5M145%
EBITDA-139.66M25.5M-548%
Gain YTD-45.0002.814-1,599%
P/E RatioN/A4.78-
Revenue374K0-
Total Cash71.2M153M47%
Total Debt213M486K43,827%
FUNDAMENTALS RATINGS
MCRB vs ORMP: Fundamental Ratings
MCRB
ORMP
OUTLOOK RATING
1..100
7668
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
54
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10054
PRICE GROWTH RATING
1..100
6559
P/E GROWTH RATING
1..100
10099
SEASONALITY SCORE
1..100
4619

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORMP's Valuation (54) in the Pharmaceuticals Other industry is in the same range as MCRB (77) in the Biotechnology industry. This means that ORMP’s stock grew similarly to MCRB’s over the last 12 months.

ORMP's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as MCRB (100) in the Biotechnology industry. This means that ORMP’s stock grew similarly to MCRB’s over the last 12 months.

ORMP's SMR Rating (54) in the Pharmaceuticals Other industry is somewhat better than the same rating for MCRB (100) in the Biotechnology industry. This means that ORMP’s stock grew somewhat faster than MCRB’s over the last 12 months.

ORMP's Price Growth Rating (59) in the Pharmaceuticals Other industry is in the same range as MCRB (65) in the Biotechnology industry. This means that ORMP’s stock grew similarly to MCRB’s over the last 12 months.

ORMP's P/E Growth Rating (99) in the Pharmaceuticals Other industry is in the same range as MCRB (100) in the Biotechnology industry. This means that ORMP’s stock grew similarly to MCRB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MCRBORMP
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
74%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 12 days ago
86%
Bullish Trend 16 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 11 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
78%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
View a ticker or compare two or three
Ad is loading...
MCRB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME20.910.41
+2.00%
GameStop Corp
SPY576.13-1.01
-0.18%
SPDR® S&P 500® ETF Trust
AAPL229.04-0.50
-0.22%
Apple
BTC.X60274.500000-307.601560
-0.51%
Bitcoin cryptocurrency
TSLA238.77-2.28
-0.95%
Tesla

MCRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, MCRB has been loosely correlated with ORMP. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if MCRB jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MCRB
1D Price
Change %
MCRB100%
+3.65%
ORMP - MCRB
42%
Loosely correlated
-1.04%
AXON - MCRB
38%
Loosely correlated
-0.78%
AMRN - MCRB
36%
Loosely correlated
+0.48%
ARRY - MCRB
34%
Loosely correlated
-5.64%
ALNY - MCRB
34%
Loosely correlated
+2.85%
More

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with KRYS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
-1.04%
KRYS - ORMP
48%
Loosely correlated
+0.68%
ALDX - ORMP
45%
Loosely correlated
+1.92%
BPMC - ORMP
44%
Loosely correlated
-0.70%
BTAI - ORMP
44%
Loosely correlated
-5.05%
INO - ORMP
44%
Loosely correlated
-1.46%
More